| Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis K Newton, DL Dugger, KE Wickliffe, N Kapoor, MC de Almagro, D Vucic, ... Science 343 (6177), 1357-1360, 2014 | 673 | 2014 |
| SARS-CoV-2 B. 1.1. 7 (alpha) and B. 1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains P Radvak, HJ Kwon, M Kosikova, U Ortega-Rodriguez, R Xiang, JN Phue, ... Nature communications 12 (1), 6559, 2021 | 78 | 2021 |
| Structural evidence for a sequential release mechanism for activation of heterotrimeric G proteins N Kapoor, ST Menon, R Chauhan, P Sachdev, TP Sakmar Journal of molecular biology 393 (4), 882-897, 2009 | 64 | 2009 |
| Nucleobindin 1 is a calcium-regulated guanine nucleotide dissociation inhibitor of Gαi1 N Kapoor, R Gupta, ST Menon, E Folta-Stogniew, DP Raleigh, TP Sakmar Journal of biological chemistry 285 (41), 31647-31660, 2010 | 43 | 2010 |
| Malaria derived glycosylphosphatidylinositol anchor enhances anti-Pfs25 functional antibodies that block malaria transmission N Kapoor, I Vanjak, J Rozzelle, A Berges, W Chan, G Yin, C Tran, AK Sato, ... Biochemistry 57 (5), 516-519, 2018 | 38 | 2018 |
| Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current … J Fairman, P Agarwal, S Barbanel, C Behrens, A Berges, J Burky, ... Vaccine 39 (23), 3197-3206, 2021 | 31 | 2021 |
| Site-specific conjugation of cell wall polyrhamnose to protein SpyAD envisioning a safe universal group A streptococcal vaccine NJ Gao, S Uchiyama, L Pill, S Dahesh, J Olson, L Bautista, S Maroju, ... Infectious Microbes & Diseases 3 (2), 87-100, 2021 | 29 | 2021 |
| Nucleobindin 1 caps human islet amyloid polypeptide protofibrils to prevent amyloid fibril formation R Gupta, N Kapoor, DP Raleigh, TP Sakmar Journal of molecular biology 421 (2-3), 378-389, 2012 | 29 | 2012 |
| Repertoire of naturally acquired maternal antibodies transferred to infants for protection against shigellosis E Ndungo, LR Andronescu, AG Buchwald, JM Lemme-Dumit, P Mawindo, ... Frontiers in Immunology 12, 725129, 2021 | 15 | 2021 |
| Non-native amino acid click chemistry-based technology for site-specific polysaccharide conjugation to a bacterial protein serving as both carrier and vaccine antigen N Kapoor, S Uchiyama, L Pill, L Bautista, A Sedra, L Yin, M Regan, E Chu, ... ACS omega 7 (28), 24111-24120, 2022 | 14 | 2022 |
| A Porphyromonas gingivalis Capsule-Conjugate Vaccine Protects From Experimental Oral Bone Loss FG Rocha, A Berges, A Sedra, S Ghods, N Kapoor, L Pill, ME Davey, ... Frontiers in Oral Health 2, 686402, 2021 | 7 | 2021 |
| A Novel Shigella O-Polysaccharide–IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes G Desalegn, N Kapoor, L Pill-Pepe, L Bautista, L Yin, E Ndungo, EV Oaks, ... Msphere 8 (3), e00019-23, 2023 | 5 | 2023 |
| Efficient production of immunologically active Shigella invasion plasmid antigens IpaB and IpaH using a cell-free expression system JFMFP Neeraj Kapoor, Esther Ndungo, Lucy Pill, Girmay Desalegn, Aym Berges ... Applied Microbiology and Biotechnology, 2021 | 5* | 2021 |
| Addition of Lauryldimethylamine N-Oxide (LDAO) to a Copper-Free Click Chemistry Reaction Improves the Conjugation Efficiency of a Cell-Free Generated CRM197 Variant … L Bautista, L Pill-Pepe, N Kapoor, S Snyder, E Chu, P Agarwal, M Sardar, ... ACS omega 7 (39), 34921-34928, 2022 | 3 | 2022 |
| Site-specific antigen-adjuvant conjugation using cell-free protein synthesis enhances antigen presentation and CD8+ T-cell response AM Weiss, J Ajit, TJ Albin, N Kapoor, S Maroju, A Berges, L Pill, J Fairman, ... Scientific reports 11 (1), 6267, 2021 | 3 | 2021 |
| 1047. Development of a Next Generation 30+ Valent Pneumococcal Conjugate Vaccine (VAX-XP) Using Site-Specific Carrier Protein Conjugation C Behrens, J Fairman, P Agarwal, S Arulkumar, S Barbanel, L Bautista, ... Open Forum Infectious Diseases 8 (Supplement_1), S615-S615, 2021 | 2 | 2021 |
| The Group A Streptococcal Vaccine Candidate VAX-A1 Protects against Group B Streptococcus Infection via Cross-Reactive IgG Targeting Virulence Factor C5a … S McCabe, E Bjånes, A Hendriks, Z Wang, NM van Sorge, L Pill-Pepe, ... Vaccines 11 (12), 1811, 2023 | 1 | 2023 |
| Halting the amyloid march: How a novel Ca2+-binding protein, NUCB1, prevents the formation of amyloid fibrils R Gupta, N Kapoor, DP Raleigh, TP Sakmar Biophysical Journal 100 (3), 538a, 2011 | 1 | 2011 |
| Unzipping Amyloid Fibrils: How a Novel Calcium-Binding Protein, NUCB1, Prevents the Formation of Amyloid Fibrils N Kapoor | 1 | 2010 |
| Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human … T Rivera-Hernandez, DG Carnathan, J Richter, P Marchant, AJ Cork, ... Vaccines 12 (4), 382, 2024 | | 2024 |
Jeff FairmanVaxcyte, Inc.Verified email at vaxcyte.com
